Concepedia

David Batt

DB

17

Publications

1.6K

Citations

15

H-Index

1994

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Novartis (Switzerland)

UConn Health

Duke University Hospital

David Batt is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1994–2010

17

Publications

17

Regulation of G<sub>1</sub>progression by the<i>PTEN</i>tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway

Shivapriya Ramaswamy, Noriaki Nakamura, Francisca Vázquez et al. · Proceedings of the National Academy of Sciences · 1999 · 604 citations · Full text

, , +17

An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells

Qing Sheng, Xinggang Liu, Eleanor Fleming et al. · Cancer Cell · 2010 · 230 citations · Full text

, , +10

Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with <i>RET/PTC</i> or <i>BRAF</i> Mutations <i>In vitro</i> and <i>In vivo</i>

Bin Ouyang, Jeffrey A. Knauf, Eric P. Smith et al. · Clinical Cancer Research · 2006 · 136 citations · Full text

Heregulin Induces Phosphorylation of BRCA1 through Phosphatidylinositol 3-Kinase/AKT in Breast Cancer Cells

Soner Altiok, David Batt, Nedret Altıok et al. · Journal of Biological Chemistry · 1999 · 121 citations · Full text

Targeting <i>BRAF</i>V600E in thyroid carcinoma: therapeutic implications

Constantine S. Mitsiades, Joseph Negri, Ciaran J. McMullan et al. · Molecular Cancer Therapeutics · 2007 · 57 citations · Full text

, , +16

Rows per page

1–5 of 17